Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
9,621
+4,802
+100% +$562K 0.21% 52
2026
Q1
$580K Sell
4,819
-1,797
-27% -$207K 0.11% 85
2025
Q4
$696K Buy
6,616
+103
+2% +$9.67K 0.13% 74
2025
Q3
$547K Buy
6,513
+1,025
+19% +$84.4K 0.11% 88
2025
Q2
$434K Buy
5,488
+302
+6% +$24K 0.09% 91
2025
Q1
$465K Sell
5,186
-14,052
-73% -$1.31M 0.11% 90
2024
Q4
$1.91M Sell
19,238
-629
-3% -$64.8K 0.3% 78
2024
Q3
$2.26M Buy
19,867
+1,566
+9% +$186K 0.36% 71
2024
Q2
$2.27M Sell
18,301
-8,347
-31% -$1.08M 0.4% 67
2024
Q1
$3.52M Buy
26,648
+10
+0% +$1.23K 0.65% 46
2023
Q4
$2.9M Sell
26,638
-290
-1% -$30.1K 0.63% 48
2023
Q3
$2.77M Buy
26,928
+327
+1% +$35.2K 0.68% 41
2023
Q2
$3.07M Buy
26,601
+1,489
+6% +$169K 0.76% 37
2023
Q1
$2.67M Buy
25,112
+2,574
+11% +$278K 0.68% 40
2022
Q4
$2.5M Buy
22,538
+1,323
+6% +$135K 0.69% 40
2022
Q3
$1.83M Buy
21,215
+60
+0.3% +$5.36K 0.51% 55
2022
Q2
$1.93M Buy
21,155
+426
+2% +$37.8K 0.5% 60
2022
Q1
$1.7M Buy
20,729
+470
+2% +$37.1K 0.4% 60
2021
Q4
$1.55M Buy
+20,259
New +$1.61M 0.37% 63

Other funds holding MRK

JMAC Enterprises's MRK Position: Q2 2026 in Review

JMAC Enterprises increased its Merck (MRK) stake by 100% in Q2 2026, buying an estimated $562K and bringing the position to 9,621 shares worth $1.24M. The position accounts for 0.21% of the portfolio, ranked #52.

JMAC Enterprises first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.52M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • JMAC Enterprises held 9,621 shares of Merck worth $1.24M as of Q2 2026.
  • JMAC Enterprises bought 4,802 Merck shares in Q2 2026, an estimated $562K.
  • Merck made up 0.21% of JMAC Enterprises's portfolio in Q2 2026, its #52 holding.
  • JMAC Enterprises first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • JMAC Enterprises's Merck position peaked at $3.52M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.